Olgu Sunumu
Yıl 2018,
Cilt: 43 Sayı: 2, 480 - 483, 30.06.2018
Öz
The most common benign neoplasm seen in the liver is haemangioma. It is usually asymptomatic and rarely causes complications. Liver and synchronous organ involvement can be seen. It is usually followed by medical. If symptomatic, rapid growth and diagnosis is uncertain, surgical treatment should be performed. In this article, a case who presented with synchronous haemangima on liver and diaphragma has been reported.
Anahtar Kelimeler
Kaynakça
- 1. Hoekstra L, Bieze M, Erdogan D,Roelofs J, Beuers U, vanGulik T. Management of giant liver hemangiomas: an update. Expert Rev Gastroenterol Hepatol .2013;7:263-8. 2. Giannitrapani L, Soresi M, La Spada E, Cervello M , D’Alessandro N, Montalto G. Sex hormones and risk of liver tumor. Ann NY Acad Sci. 2006;1089:228-36. 3. Spitzer D, Krainz R, Graf AH, Menzel C, Staudach A. Pregnancy after ovarian stimulation and intrauterine insemination in a woman with cavernous macrohemangioma of the liver. A case report. J Reprod Med. 1997;42:809-12. 4. Reddy KR, Kligerman S, Levi J, Livingstone A, Molina E,Franceschi D et al. Benign and solid tumors of the liver:relationship to sex, age, size of tumors, and outcome. AmSurg. 2001;67:173-8. 5. Baer H, Dennison A, Mouton W, Stain S, Zimmermann A, Blumgart L. Enucleation of giant hemangiomas of the liver. Annals of Surgery. 1992; 216: 673-676. 6. Duxbury M,Garden O. Giant haemangioma of the liver: observation or resection. Dig Surg. 2010;27:7-11. 7. Kong J, Anaya D. A giant cavernous hemangioma of the liver extending int the pelvis. Int J Surg Case Rep. 2015;13:51-4. 8. Farges O, Daradkeh S, Bismuth H. Cavernous hemangiomas of the liver: are there any indications for resection? World J Surg. 1995;19:19-24. 9. 9.Belli G, D’Agostino A, Iannelli A, Marano I. Hepatic incidentaloma. Retrospective analysis of 35 cases. Int Surg. 1996;81:144-8. 10. 10 . Miura J, Amini A, Schmocker R, Nichols S, Sukato D, Winslow E et al. Surgical management of hepatic hemangiomas: a multi-institutional experience. HPB (Oxford). 2014;16:924–8. 11. 11.van Tilborg AA, Nielsen K, Scheffer HJ, van den Tol P, van Waesberghe JH, Sietses C et al. Bipolar radiofrequency ablation for symptomatic giant (>10 cm) hepatic cavernous haemangiomas: initial clinical experience. Clin Radiol. 2013;68:e9-14. 12. Toro A, Mahfouz AE, Ardiri A, Malaguarnera M,Malaguarnera G, Loria F et al. What is changing in indications and treatment of hepatic hemangiomas. A review. Ann Hepatol. 2014;13:327-39. 13. Di Carlo I, Koshy R, Al Mudares S, Ardiri A, Bertino G,Toro A. Giant cavernous liver hemangiomas: is it the time to change the size categories? Hepatobiliary Pancreat Dis. Int. 2016;15:21-9. 14. Chatzoulis G, Kaltsas A, Daliakopoulos S, Sallam O, Maria K, Chatzoulis K et al. Co-existence of a giant splenic hemangioma and multiple hepatic hemangiomas and the potential association with the use of oral contraceptives: a case report. J Med Case Reports. 2008;2:147. 15. Xiao X, Liu J, Sheng M. Synergistic effect of estrogen and VEGF on the proliferation of hemangioma vascular endothelial cells. J Pediatr Surg. 2004;39:1107-10. 16. Paulo Neto WT, Koifman ACB. Martins CAS. Rupture hepatic cavernous hemangioma: a cause report and literature review. Radiol Bras. 2009;42:271-3
Yıl 2018,
Cilt: 43 Sayı: 2, 480 - 483, 30.06.2018
Öz
Karaciğerde görülen en sık benign neoplazm hemanjiyomdur. Genellikle asemptomatik olup ender olarak komplikasyon oluşturabilir. Karaciğer ve senkron organ tutulumu görülebilir. Genellikle medikal takip edilir. Semptomatik, hızlı büyüme gösterir ve tanı kesin değilse cerrahi tedavi uygulanmalıdır. Bu yazıda karaciğer ve diaframda aynı dönemde görülen senkron hemanjiyomu olan bir olgu sunulmuştur.
Anahtar Kelimeler
Kaynakça
- 1. Hoekstra L, Bieze M, Erdogan D,Roelofs J, Beuers U, vanGulik T. Management of giant liver hemangiomas: an update. Expert Rev Gastroenterol Hepatol .2013;7:263-8. 2. Giannitrapani L, Soresi M, La Spada E, Cervello M , D’Alessandro N, Montalto G. Sex hormones and risk of liver tumor. Ann NY Acad Sci. 2006;1089:228-36. 3. Spitzer D, Krainz R, Graf AH, Menzel C, Staudach A. Pregnancy after ovarian stimulation and intrauterine insemination in a woman with cavernous macrohemangioma of the liver. A case report. J Reprod Med. 1997;42:809-12. 4. Reddy KR, Kligerman S, Levi J, Livingstone A, Molina E,Franceschi D et al. Benign and solid tumors of the liver:relationship to sex, age, size of tumors, and outcome. AmSurg. 2001;67:173-8. 5. Baer H, Dennison A, Mouton W, Stain S, Zimmermann A, Blumgart L. Enucleation of giant hemangiomas of the liver. Annals of Surgery. 1992; 216: 673-676. 6. Duxbury M,Garden O. Giant haemangioma of the liver: observation or resection. Dig Surg. 2010;27:7-11. 7. Kong J, Anaya D. A giant cavernous hemangioma of the liver extending int the pelvis. Int J Surg Case Rep. 2015;13:51-4. 8. Farges O, Daradkeh S, Bismuth H. Cavernous hemangiomas of the liver: are there any indications for resection? World J Surg. 1995;19:19-24. 9. 9.Belli G, D’Agostino A, Iannelli A, Marano I. Hepatic incidentaloma. Retrospective analysis of 35 cases. Int Surg. 1996;81:144-8. 10. 10 . Miura J, Amini A, Schmocker R, Nichols S, Sukato D, Winslow E et al. Surgical management of hepatic hemangiomas: a multi-institutional experience. HPB (Oxford). 2014;16:924–8. 11. 11.van Tilborg AA, Nielsen K, Scheffer HJ, van den Tol P, van Waesberghe JH, Sietses C et al. Bipolar radiofrequency ablation for symptomatic giant (>10 cm) hepatic cavernous haemangiomas: initial clinical experience. Clin Radiol. 2013;68:e9-14. 12. Toro A, Mahfouz AE, Ardiri A, Malaguarnera M,Malaguarnera G, Loria F et al. What is changing in indications and treatment of hepatic hemangiomas. A review. Ann Hepatol. 2014;13:327-39. 13. Di Carlo I, Koshy R, Al Mudares S, Ardiri A, Bertino G,Toro A. Giant cavernous liver hemangiomas: is it the time to change the size categories? Hepatobiliary Pancreat Dis. Int. 2016;15:21-9. 14. Chatzoulis G, Kaltsas A, Daliakopoulos S, Sallam O, Maria K, Chatzoulis K et al. Co-existence of a giant splenic hemangioma and multiple hepatic hemangiomas and the potential association with the use of oral contraceptives: a case report. J Med Case Reports. 2008;2:147. 15. Xiao X, Liu J, Sheng M. Synergistic effect of estrogen and VEGF on the proliferation of hemangioma vascular endothelial cells. J Pediatr Surg. 2004;39:1107-10. 16. Paulo Neto WT, Koifman ACB. Martins CAS. Rupture hepatic cavernous hemangioma: a cause report and literature review. Radiol Bras. 2009;42:271-3
Toplam 1 adet kaynakça vardır.
Ayrıntılar
| Birincil Dil | Türkçe |
|---|---|
| Konular | Sağlık Kurumları Yönetimi |
| Bölüm | Olgu Sunumu |
| Yazarlar | |
| Yayımlanma Tarihi | 30 Haziran 2018 |
| Kabul Tarihi | 23 Ağustos 2017 |
| Yayımlandığı Sayı | Yıl 2018 Cilt: 43 Sayı: 2 |
